Trump to announce all 50 states joining Medicaid drug pricing model
Americas4 sources2 countries5m ago
President Donald Trump announced that all 50 U.S. states are participating in a new Medicaid program designed to lower the costs of certain prescription drugs. The initiative utilizes a "most favored nation" pricing model to reduce the net cost of selected medications for the program.
The policy aims to align Medicaid drug pricing with international benchmarks, effectively lowering expenditures for the selected drugs. The announcement confirms nationwide participation in the effort to address pharmaceutical affordability within the federal-state health insurance system.
In-depth summary · AI, neutral
How the coverage differs
Same story, different emphasis — here's what each outlet chose to lead with.
Toronto StarFocuses on the economic impact of lowering net drug prices